Search research articles
Contact Us
Filters
Showing results (71-80 of 75) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 75 results.
Journal of Proteome Research
|
September 2, 2021
Analysis of Metabolite and Lipid Association Networks Reveals Molecular Mechanisms Associated with 3-Month Mortality and Poor Functional Outcomes in Patients with Acute Ischemic Stroke after Thrombolytic Treatment with Recombinant Tissue Plasminogen Activator
Cristina Licari, Leonardo Tenori, Betti Giusti, et al.
Journal of Proteome Research
|
December 5, 2022
Nuclear Magnetic Resonance-Based Metabolomics to Predict Early and Late Adverse Outcomes in Ischemic Stroke Treated with Intravenous Thrombolysis
Cristina Licari, Leonardo Tenori, Francesca Di Cesare, et al.
Diagnostics (Basel, Switzerland)
|
January 10, 2026
Bicuspid Aortic Valve: Old and Novel Gene Contribution to Disease Onset and Complications
Elena Sticchi, Rosina De Cario, Samuele Suraci, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
March 8, 2017
Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis
Anna Maria Gori, Betti Giusti, Benedetta Piccardi, et al.
Frontiers in Neurology
|
June 16, 2015
Unbalanced Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinases Ratios Predict Hemorrhagic Transformation of Lesion in Ischemic Stroke Patients Treated with Thrombolysis: Results from the MAGIC Study
Benedetta Piccardi, Vanessa Palumbo, Mascia Nesi, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 75) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 75 results.
Journal of Proteome Research
|
September 2, 2021
Analysis of Metabolite and Lipid Association Networks Reveals Molecular Mechanisms Associated with 3-Month Mortality and Poor Functional Outcomes in Patients with Acute Ischemic Stroke after Thrombolytic Treatment with Recombinant Tissue Plasminogen Activator
Cristina Licari, Leonardo Tenori, Betti Giusti, et al.
Journal of Proteome Research
|
December 5, 2022
Nuclear Magnetic Resonance-Based Metabolomics to Predict Early and Late Adverse Outcomes in Ischemic Stroke Treated with Intravenous Thrombolysis
Cristina Licari, Leonardo Tenori, Francesca Di Cesare, et al.
Diagnostics (Basel, Switzerland)
|
January 10, 2026
Bicuspid Aortic Valve: Old and Novel Gene Contribution to Disease Onset and Complications
Elena Sticchi, Rosina De Cario, Samuele Suraci, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
March 8, 2017
Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis
Anna Maria Gori, Betti Giusti, Benedetta Piccardi, et al.
Frontiers in Neurology
|
June 16, 2015
Unbalanced Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinases Ratios Predict Hemorrhagic Transformation of Lesion in Ischemic Stroke Patients Treated with Thrombolysis: Results from the MAGIC Study
Benedetta Piccardi, Vanessa Palumbo, Mascia Nesi, et al.
Page
of 8